Joshua A. Kazam serves as Executive at Nile Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Joshua A. Kazam has executed 51 insider transactions totaling $331.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 11, 2008 involved purchasing 4,100 shares valued at $3.4K.
Joshua A. Kazam currently holds 350,763 shares of Nile Therapeutics, Inc. (NLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joshua A. Kazam has been a net buyer of NLTX stock. They have purchased $331.5K and sold $0 worth of shares.
Joshua A. Kazam's most recent insider trade was on Dec 11, 2008, when they purchased 4,100 shares at $0.82 per share.
Get notified when new Form 4 filings are submitted